LABCORP HOLDINGS INC. — Director's Dealing 2020

Feb 11, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LABORATORY CORP OF AMERICA HOLDINGS (LH)
CIK: 0000920148
Period of Report: 2020-02-07

Reporting Person: van der Vaart Sandra D (SVP, Global General Counsel)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-02-07	Common Stock	M	367	—	Acquired	2762.8788	Direct
2020-02-07	Common Stock	F	101	$182.33	Disposed	2661.8788	Direct
2020-02-10	Common Stock	S	133	$181.99	Disposed	2528.8788	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-02-07	Restricted Stock Unit	$	M	367	Disposed		Common Stock (367)	Direct

Footnotes

F1: Each restricted stock unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.

F2: Amount includes 37.511 shares acquired on June 28, 2019 and 30.121 shares acquired on December 31, 2019 under the Laboratory Corporation of America Holdings 2016 Employee Stock Purchase Plan.

F3: Stock withholding to satisfy tax withholding obligations.

F4: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934.

F5: The Restricted Stock Units vested in three equal annual installments beginning on February 7, 2018 and are now fully vested.

F6: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.